Natixis’s NeoGenomics NEO Stock Holding History

Natixis’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.19K	Hold	150	–	–	﹤0.01%	1111
2026 Q1	$1.11K	Buy	+150	New	+$1.58K	﹤0.01%	1062
2025 Q4	–	Sell	-150	Closed	-$1.16K	–	1239
2025 Q3	$1.16K	Hold	150	–	–	﹤0.01%	1029
2025 Q2	$1.1K	Hold	150	–	–	﹤0.01%	993
2025 Q1	$1.36K	Hold	150	–	–	﹤0.01%	926
2024 Q4	$2.47K	Hold	150	–	–	﹤0.01%	987
2024 Q3	$2.21K	Hold	150	–	–	﹤0.01%	894
2024 Q2	$2.08K	Hold	150	–	–	﹤0.01%	927
2024 Q1	$2.36K	Hold	150	–	–	﹤0.01%	948
2023 Q4	$2.43K	Hold	150	–	–	﹤0.01%	976
2023 Q3	$1.84K	Sell	150 -151	-50%	-$2.25K	﹤0.01%	924
2023 Q2	$4.84K	Sell	301 -111	-27%	-$1.83K	﹤0.01%	953
2023 Q1	$7.17K	Sell	412 -51	-11%	-$727	﹤0.01%	905
2022 Q4	$4.28K	Buy	+463	New	+$4.32K	﹤0.01%	1023

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Natixis's NEO Position: Q2 2026 in Review

Natixis held its NeoGenomics (NEO) position steady in Q2 2026 at 150 shares worth $2.19K. The position accounts for ﹤0.01% of the portfolio, ranked #1111.

Natixis first reported a position in NEO in Q4 2022 and has held it in 14 quarters since. The position peaked at $7.17K in Q1 2023. 267 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

Natixis held 150 shares of NeoGenomics worth $2.19K as of Q2 2026.
Natixis left its NeoGenomics share count unchanged in Q2 2026.
NeoGenomics made up ﹤0.01% of Natixis's portfolio in Q2 2026, its #1111 holding.
Natixis first reported a position in NeoGenomics in Q4 2022 and has held it in 14 quarters since.
Natixis's NeoGenomics position peaked at $7.17K in Q1 2023.
267 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Natixis's 13F filing for Q2 2026, filed 13 Aug 2026.